More than a year after scientists identified the first cases of COVID-19, infection rates continue to rise in regions across
Read MoreThere is an urgent need to accelerate vaccination distribution for vulnerable Americans by overcoming problems involving social determinants of health.
Read MoreCMS has finalized a series of policy and technical changes to Medicare Advantage (MA) and the Medicare Prescription Drug Benefit
Read MorePharmacy-led telehealth strategies will position Special Needs Plans (SNPs) for Star Ratings success during the pandemic and for years to
Read MoreMedicare Advantage (MA) Star Ratings are the most critical evaluation of MA Prescription Drug plans, standing as a designation of
Read MoreThe most recent data from the Centers for Medicare and Medicaid Services (CMS) estimates that across the United States, there
Read MoreCenters for Medicare and Medicaid Services (CMS) has announced some key changes to the Medicare Advantage (MA) Star Ratings formula
Read MoreMedicare Advantage plans face many challenges when trying to increase their Star Ratings. Health literacy—more specifically, poor health plan literacy—is
Read MoreWhen it comes to Consumer Assessment of Healthcare Providers and Systems (CAHPS), even Medicare Advantage health plans that currently perform
Read MoreSignificant changes are coming to Medicare Advantage Star Ratings. CMS is quadruple-weighting Consumer Assessment of Healthcare Providers and Systems (CAHPS)
Read More